Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Diabetes Mellitus, Type 2”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06945406
What this trial is testing

LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 124
Early research (Phase 1)Study completedNCT00394030
What this trial is testing

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 63
Early research (Phase 1)Study completedNCT00897390
What this trial is testing

Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 24
Early research (Phase 1)Study completedNCT06226727
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Who this might be right for
Type 2 Diabetes MellitusEssential Hypertension
Boryung Pharmaceutical Co., Ltd 52
Early research (Phase 1)Study completedNCT01102673
What this trial is testing

Single Dose Study of PF-04991532 in Healthy Subjects

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 18
Early research (Phase 1)Ended earlyNCT02120976
What this trial is testing

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

Who this might be right for
Diabetes Mellitus
Akros Pharma Inc. 85
Early research (Phase 1)Study completedNCT02106585
What this trial is testing

Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus
Akros Pharma Inc. 94
Not applicableStudy completedNCT02796950
What this trial is testing

The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion

Who this might be right for
Diabetes Mellitus Type 2
University of Aarhus 8
Early research (Phase 1)Study completedNCT00904176
What this trial is testing

Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 30
Early research (Phase 1)Study completedNCT04524832
What this trial is testing

Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 290
Early research (Phase 1)Study completedNCT00908271
What this trial is testing

Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 7
Early research (Phase 1)Study completedNCT02637037
What this trial is testing

Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

Who this might be right for
BioequivalenceFixed Dose Combination TabletsHealthy Male and Female Subjects
AstraZeneca 80
Early research (Phase 1)Study completedNCT06636877
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Who this might be right for
Essential HypertensionType 2 Diabetes
Boryung Pharmaceutical Co., Ltd 52
Early research (Phase 1)Study completedNCT03444467
What this trial is testing

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 36
Early research (Phase 1)Study completedNCT05363774
What this trial is testing

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Who this might be right for
Healthy Volunteers (Diabetes Mellitus, Type 2)
Novo Nordisk A/S 161
Early research (Phase 1)Study completedNCT05232708
What this trial is testing

A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

Who this might be right for
Healthy Volunteers (Diabetes Mellitus, Type 2)
Novo Nordisk A/S 18
Early research (Phase 1)Study completedNCT06246175
What this trial is testing

HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Not applicableStudy completedNCT01077323
What this trial is testing

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

Who this might be right for
Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies)Healthy Subjects (Treated With no Diabetes Therapies)
AstraZeneca 363,766
Early research (Phase 1)Study completedNCT02361138
What this trial is testing

The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 48
Not applicableStudy completedNCT03362398
What this trial is testing

Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
British University In Egypt 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation